Portal de investigación
Position Paper on Nasal Obstruction: Evaluation and Treatment
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Valero A
- Navarro AM
- Del Cuvillo A
- Alobid I
- Benito JR
- Colás C
- de Los Santos G
- Fernández Liesa R
- García-Lliberós A
- González-Pérez R
- Izquierdo-Domínguez A
- Jurado-Ramos A
- Lluch-Bernal MM
- Montserrat Gili JR
- Mullol J
- Puiggròs Casas A
- Sánchez-Hernández MC
- Vega F
- Villacampa JM
- Dordal MT
- SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology, Allergy and Skull Base Co
Grupos
Abstract
Nasal obstruction (NO) is defined as the subjective perception of discomfort or difficulty in the passage of air through the nostrils. It is a common reason for consultation in primary and specialized care and may affect up to 30%-40% of the population. It affects quality of life (especially sleep) and lowers work efficiency. The aim of this document is to agree on how to treat NO, establish a methodology for evaluating and diagnosing it, and define an individualized approach to its treatment. NO can be unilateral or bilateral, intermittent or persistent and may be caused by local or systemic factors, which may be anatomical, inflammatory, neurological, hormonal, functional, environmental, or pharmacological in origin. Directed study of the medical history and physical examination are key for diagnosing the specific cause. NO may be evaluated using subjective assessment tools (visual analog scale, symptom score, standardized questionnaires) or by objective estimation (active anterior rhinomanometry, acoustic rhinometry, peak nasal inspiratory flow). Although there is little correlation between the results, they may be considered complementary and not exclusive. Assessing the impact on quality of life through questionnaires standardized according to the underlying disease is also advisable. NO is treated according to its cause. Treatment is fundamentally pharmacological (topical and/or systemic) when the etiology is inflammatory or functional. Surgery may be necessary when medical treatment fails to :complement or improve medical treatment or when other therapeutic approaches are not possible. Combinations of surgical techniques and medical treatment may be necessary.
Datos de la publicación
- ISSN/ISSNe:
- 1018-9068, 1698-0808
- Tipo:
- Review
- Páginas:
- 67-90
- DOI:
- 10.18176/jiaci.0232
- Factor de Impacto:
- 0,784 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY ESMON PUBLICIDAD S A
Citas Recibidas en Web of Science: 35
Documentos
- No hay documentos
Filiaciones
Keywords
- Nasal obstruction/nasal blockage/nasal respiratory insufficiency; Objective and subjective evaluation; Acoustic rhinometry; Rhinomanometry; Medical and surgical treatment
Proyectos asociados
ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE 52 SEMANAS DE DURACIÓN, CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DUPILUMAB EN PACIENTES CON POLIPOSIS NASAL BILATERAL EN TRATAMIENTO DE BASE CON CORTICOSTEROIDES INTRANASALES.
Investigador Principal: MIGUEL ARMENGOT CARCELLER
EFC14280 . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2017
ESTUDIO EN FASE IIB, DOBLE CIEGO, ALEATORIZADO, CONTROLADO CON PLACEBO, CON GRUPOS PARALELOS Y DE BÚSQUEDA DE DOSIS DE PF-06651600 Y PF-06700841 POR VÍA ORAL COMO TRATAMIENTO DE INDUCCIÓN Y TRATAMIENTO CRÓNICO EN PACIENTES CON COLITIS ULCEROSA MODERADA O GRAVE.
Investigador Principal: MARISA IBORRA COLOMINO
B7981005 . 2017
Cita
Valero A,Navarro AM,Del Cuvillo A,Alobid I,Benito JR,Colás C,de Los Santos G,Fernández R,García A,González R,Izquierdo A,Jurado A,Lluch MM,Montserrat JR,Mullol J,Puiggròs A,Sánchez MC,Vega F,Villacampa JM,Armengot M,Dordal MT,SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology AASBC. Position Paper on Nasal Obstruction: Evaluation and Treatment. J Investig Allergol Clin Immunol. 2018. 28(2):p. 67-90. IF:3,802. (2).